Moscow: September 17, 2020. Russia laga sovereign wealth fund para Indian drug company Dr Reddy’s Laboratories logot coronavirus vaccine toh 100 million doses supply koribo koikena fund para Wednesday din te koishe. Moscow laga plan toh jolti para kam koikena bahar desh te be thibo. Sputnik-V vaccine candidate toh Russian Direct Investment Fund (RDIF) para aha ase aro tai khan Indian manufacturers khan logot agreement bonaikena Indai te 300 million doses bonabo ase aro etu oper te India toh Russian hath para oil aro arms be loi thaki. Agreement hesab te, sob melaikena 200 million supply botaboli junaishe. Latin America ke half thibo aro India logot half botabo. RDIF para koishe ke, 1 billion doses mangikena ase. India laga population toh 1,3 billion oper ase, tai khan ke 2020 saal kotom samay thibo, RDIF para koishe. Phase III trials te, komti hoilebi 40,000 manuh khan Russia te loiase. Results toh October nahoile November moina te babo koikena RDIF head Kirill Dmitriev para koishe. Dr Reddy toh India laga top pharmaceutical companies ase aro tai para India te Sputnik-V Phase III clinical trials toh koriboli ase. India te trails toh aha moina para soruh koribo, koikena Dmitriev para Reuters ke koishe, aro trial results toh Sputnik-V laga domestic regulatory approval India te jabole deya beche hobo. Jaa hafta India para coronavirus vaccine nemite emergency authorization toh manibo koishe. Umer tangor manuh aro high-risk te kam kora manuh nemite ase. Etu agreement toh Wednesday din te fesla hoishe, India laga coronavirus cases toh 5 million oper hoishe, hospital solak khan pressure uthishe, keli koile oxygen supply komti hoiase aro tai khan hazar bemari manuh ke saboli nemite.
Add Comment